Rising Drug Patent Portfolio
Rising owns 1 orange book drug protected by 2 US patents Given below is the list of Rising's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7553835 | Topical antifungal composition | 19 Oct, 2018 | Expired |
| US8026238 | Topical antifungal composition | 19 Oct, 2018 | Expired |
Latest Legal Activities on Rising's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Rising.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 30 Oct, 2023 | US8026238 |
|
Maintenance Fee Reminder Mailed
Critical
| 15 May, 2023 | US8026238 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 20 Mar, 2019 | US8026238 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 14 Nov, 2016 | US8026238 |
|
Email Notification
Critical
| 14 Nov, 2016 | US8026238 |
|
Correspondence Address Change
Critical
| 10 Nov, 2016 | US8026238 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 01 Oct, 2013 | US8026238 |
|
Email Notification
Critical
| 01 Oct, 2013 | US8026238 |
|
Correspondence Address Change
Critical
| 30 Sep, 2013 | US8026238 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 27 Sep, 2011 | US8026238 |
|
Recordation of Patent Grant Mailed
Critical
| 27 Sep, 2011 | US8026238 |
|
Issue Notification Mailed
Critical
| 07 Sep, 2011 | US8026238 |
| Dispatch to FDC | 26 Aug, 2011 | US8026238 |
|
Mail Response to 312 Amendment (PTO-271)
Critical
| 25 Aug, 2011 | US8026238 |
|
Response to Amendment under Rule 312
Critical
| 24 Aug, 2011 | US8026238 |
Rising's Family Patents
Recent FDA approvals and tentative approvals for Rising
This section lists recent FDA approvals and tentative approvals for Lupin, covering innovator and generic drugs with key regulatory details and timelines.
Generic drugs
Includes generic drug submissions with tentative FDA approvals, not yet marketable due to patent or exclusivity restrictions.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Acetylcysteine |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 17 Nov, 2015 |
Rising Drug List
Given below is the complete list of Rising's drugs and the patents protecting them.
1. Extina
Extina is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7553835 | Topical antifungal composition |
19 Oct, 2018
(7 years ago)
| Expired |
| US8026238 | Topical antifungal composition |
19 Oct, 2018
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Extina's drug page